glp-1 gip and glucagon Glucagon-like peptide-1 The Road towards Triple Agonists:

1 Of those, 135 letters were based on an FDA inspection (inspection-based warning letters), including 16 letters issued to clinical investigators or sponsors following inspections conducted as part of the FDAs Bioresearch Monitoring (BIMO) Program

Whats needed in order to fully implement GLP-1s as a treatment option for HS

GLP-1 medications should not be taken if: You or a family member have a history of medullary thyroid cancer/MEN2 syndrome You have a history of pancreatitis You are pregnant or trying to become pregnant How do non-GLP-1 appetite suppressants work

The medication is still working

Learn to recognise hypoglycaemia symptoms (tremor, sweating, confusion, palpitations) and appropriate management strategies

After withdrawal, apply firm but gentle pressure to the injection site using a clean finger or gauze for 10 to 20 seconds